Trade Precision BioSciences, Inc. - DTIL CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0816 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 5.7842 |
| Open | 5.8742 |
| 1-Year Change | -54.39% |
| Day's Range | 5.6742 - 6.0442 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 5.9042 | 0.0400 | 0.68% | 5.8642 | 6.0442 | 5.6742 |
| Feb 20, 2025 | 5.7842 | 0.1600 | 2.84% | 5.6242 | 5.9442 | 5.4242 |
| Feb 19, 2025 | 5.5942 | 0.3100 | 5.87% | 5.2842 | 5.7742 | 5.1742 |
| Feb 18, 2025 | 5.1242 | -0.1200 | -2.29% | 5.2442 | 5.3842 | 4.9842 |
| Feb 14, 2025 | 5.2442 | 0.2700 | 5.43% | 4.9742 | 5.3542 | 4.9742 |
| Feb 13, 2025 | 5.0242 | 0.0000 | 0.00% | 5.0242 | 5.0742 | 4.9042 |
| Feb 12, 2025 | 4.9742 | 0.1000 | 2.05% | 4.8742 | 5.0542 | 4.7742 |
| Feb 11, 2025 | 4.7742 | 0.0000 | 0.00% | 4.7742 | 4.8342 | 4.6242 |
| Feb 10, 2025 | 4.7542 | 0.0800 | 1.71% | 4.6742 | 4.8242 | 4.5742 |
| Feb 7, 2025 | 4.6742 | -0.1500 | -3.11% | 4.8242 | 4.8542 | 4.6242 |
| Feb 6, 2025 | 4.7742 | -0.0500 | -1.04% | 4.8242 | 5.0042 | 4.7742 |
| Feb 5, 2025 | 4.8542 | -0.0200 | -0.41% | 4.8742 | 5.1442 | 4.8242 |
| Feb 4, 2025 | 4.9542 | 0.2800 | 5.99% | 4.6742 | 5.0142 | 4.6742 |
| Feb 3, 2025 | 4.6342 | -0.2300 | -4.73% | 4.8642 | 4.8842 | 4.6342 |
| Jan 31, 2025 | 4.9842 | 0.0100 | 0.20% | 4.9742 | 5.3242 | 4.9742 |
| Jan 30, 2025 | 5.0042 | 0.1200 | 2.46% | 4.8842 | 5.2142 | 4.8842 |
| Jan 29, 2025 | 4.8842 | -0.0900 | -1.81% | 4.9742 | 4.9942 | 4.7842 |
| Jan 28, 2025 | 4.9342 | -0.0800 | -1.60% | 5.0142 | 5.0742 | 4.7542 |
| Jan 27, 2025 | 5.0042 | -0.0100 | -0.20% | 5.0142 | 5.0942 | 4.8442 |
| Jan 24, 2025 | 4.9842 | 0.0100 | 0.20% | 4.9742 | 5.1142 | 4.7842 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Precision BioSciences, Inc. Company profile
About Precision BioSciences Inc
Precision BioSciences, Inc is a clinical stage biotechnology company. The Company’s ARCUS platform is designed to deliver therapeutic-grade genome editing. Its ARCUS genome editing technology is for deoxyribonucleic acid (DNA) genome insertion, deletion and repair. Its ARCUS is based on a naturally occurring genome editing enzyme, I-CreI, that evolved in the algae Chlamydomonas reinhardtii to make specific cuts and DNA insertions in cellular DNA. The Company’s pipeline includes Ex vivo Allogeneic CAR T Immunotherapy and In vivo Gene Correction. Its Ex vivo Allogeneic CAR T Immunotherapy pipeline offers programs, including PBCAR0191, PBCAR19B, PBCAR269A and CD19 Combination with Foralumab. Its in-vivo Gene Correction pipeline offers three preclinical programs, including PBGENE-PCSK9, PBGENE-PH1 and PBGENE-HBV. The Company’s subsidiaries include Precision PlantSciences, Inc. and Precision BioSciences UK Limited.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Precision BioSciences Inc revenues increased from $24.3M to $115.5M. Net loss decreased 72% to $30.6M. Revenues reflect Therapeutics segment increase from $21.9M to $111.7M, Food segment increase of 57% to $3.8M. Lower net loss reflects Therapeutics segment income totaling $32M vs. loss of $50M, Food segment loss decrease of 26% to $3.8M.
| Industry: | Biotechnology & Medical Research (NEC) |
302 E Pettigrew St Ste A100
DURHAM
NORTH CAROLINA 27701-2393
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com